The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Butyrate inhibits inflammatory responses through NFκB inhibition: implications for Crohn's disease
Open accessAbstract
BACKGROUND/AIM: Proinflammatory cytokines are key factors in the pathogenesis of Crohn's disease (CD). Activation of nuclear factor kappa B (NFκB), which is involved in their gene transcription, is increased in the intestinal mucosa of CD patients. As butyrate enemas may be beneficial in treating colonic inflammation, we investigated if butyrate promotes this effect by acting on proinflammatory cytokine expression. METHODS: Intestinal biopsy specimens, isolated lamina propria cells (LPMC), and peripheral blood mononuclear cells (PBMC) were cultured with or without butyrate for assessment of secretion of tumour necrosis factor (TNF) and mRNA levels. NFκB p65 activation was determined by immunofluorescence and gene reporter experiments. Levels of NFκB inhibitory protein (IκBα) were analysed by western blotting. The in vivo efficacy of butyrate was assessed in rats with trinitrobenzene sulphonic acid (TNBS) induced colitis. RESULTS: Butyrate decreased TNF production and proinflammatory cytokine mRNA expression by intestinal biopsies and LPMC from CD patients. Butyrate abolished lipopolysaccharide (LPS) induced expression of cytokines by PBMC and transmigration of NFκB from the cytoplasm to the nucleus. LPS induced NFκB transcriptional activity was decreased by butyrate while IκBα levels were stable. Butyrate treatment also improved TNBS induced colitis. CONCLUSIONS: Butyrate decreases proinflammatory cytokine expression via inhibition of NFκB activation and IκBα degradation. These anti-inflammatory properties provide a rationale for assessing butyrate in the treatment of CD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
Baldwin, A. S. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.649 · Cited by 4,979
Targan, S. R., Hanauer, S. B., van Deventer, S. J. H., Mayer, L., Present, D. H., Braakman, T., DeWoody, K. L., Schaible, T. F., & Rutgeerts, P. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710093371502 · Cited by 3,135
Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A., & Karin, M. (1995) · Science · doi:10.1126/science.270.5234.286 · Cited by 2,390
Hapten-induced model of chronic inflammation and ulceration in the rat colon
Morris, G. P., Beck, P. L., Herridge, M. S., Depew, W. T., Szewczuk, M. R., & Wallace, J. L. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)90904-9 · Cited by 1,829
Inhibition of NF-κB by Sodium Salicylate and Aspirin
Kopp, E., & Ghosh, S. (1994) · Science · doi:10.1126/science.8052854 · Cited by 1,753
Elliott, M. J., Maini, R. N., Feldmann, M., Kalden, J. R., Antoni, C., Smolen, J. S., Leeb, B., Breedveld, F. C., Macfarlane, J. D., Bijl, J. A., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90628-9 · Cited by 1,682
Espevik, T., & Nissen-Meyer, J. (1986) · Journal of Immunological Methods · doi:10.1016/0022-1759(86)90322-4 · Cited by 1,243
Signal transduction through NF-κB
May, M. J., & Ghosh, S. (1998) · Immunology Today · doi:10.1016/s0167-5699(97)01197-3 · Cited by 1,091
REINECKER, H.-C., STEFFEN, M., WITTHOEFT, T., PFLUEGER, I., SCHREIBER, S., MacDERMOTT, R. P., & RAEDLER, A. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1993.tb05997.x · Cited by 856
Neurath, M. F., Pettersson, S., Meyer Zum Büschenfelde, K.-H., & Strober, W. (1996) · Nature Medicine · doi:10.1038/nm0996-998 · Cited by 840
Cited by
Items 101–157 of 157
Uric acid in metabolic syndrome: Does uric acid have a definitive role?
Copur, S., Demiray, A., & Kanbay, M. (2022) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2022.04.022 · Cited by 287
Ryan, F. J., Ahern, A. M., Fitzgerald, R. S., Laserna-Mendieta, E. J., Power, E. M., Clooney, A. G., O’Donoghue, K. W., McMurdie, P. J., Iwai, S., Crits-Christoph, A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15342-5 · Cited by 285
Gut microbial metabolites in depression: understanding the biochemical mechanisms
Caspani, G., Kennedy, S., Foster, J. A., & Swann, J. (2019) · Microbial Cell · doi:10.15698/mic2019.10.693 · Cited by 284
Alterations in the gut microbiome of children with severe ulcerative colitis
Michail, S., Durbin, M., Turner, D., Griffiths, A. M., Mack, D. R., Hyams, J., Leleiko, N., Kenche, H., Stolfi, A., & Wine, E. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22860 · Cited by 284
Prince, A. L., Ma, J., Kannan, P. S., Alvarez, M., Gisslen, T., Harris, R. A., Sweeney, E. L., Knox, C. L., Lambers, D. S., Jobe, A. H., et al. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.01.193 · Cited by 283
Vanegas, S. M., Meydani, M., Barnett, J. B., Goldin, B., Kane, A., Rasmussen, H., Brown, C., Vangay, P., Knights, D., Jonnalagadda, S., et al. (2017) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.146928 · Cited by 277
Regulation of microglial inflammatory response by sodium butyrate and short‐chain fatty acids
Huuskonen, J., Suuronen, T., Nuutinen, T., Kyrylenko, S., & Salminen, A. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705682 · Cited by 275
Planell, N., Lozano, J. J., Mora-Buch, R., Masamunt, M. C., Jimeno, M., Ordás, I., Esteller, M., Ricart, E., Piqué, J. M., Panés, J., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-303333 · Cited by 275
Determinants of colonic barrier function in inflammatory bowel disease and potential therapeutics
Hering, N. A., Fromm, M., & Schulzke, J. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2011.224568 · Cited by 275
Aguilar, E. C., Leonel, A. J., Teixeira, L. G., Silva, A. R., Silva, J. F., Pelaez, J. M. N., Capettini, L. S. A., Lemos, V. S., Santos, R. A. S., & Alvarez-Leite, J. I. (2014) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2014.01.002 · Cited by 269
Butyrate Suppression of Colonocyte NF-κB Activation and Cellular Proteasome Activity
Yin, L., Laevsky, G., & Giardina, C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105170200 · Cited by 266
Is butyrate the link between diet, intestinal microbiota and obesity-related metabolic diseases?
Brahe, L. K., Astrup, A., & Larsen, L. H. (2013) · Obesity Reviews · doi:10.1111/obr.12068 · Cited by 264
Chriett, S., Dąbek, A., Wojtala, M., Vidal, H., Balcerczyk, A., & Pirola, L. (2019) · Scientific Reports · doi:10.1038/s41598-018-36941-9 · Cited by 263
Role of the Gut Microbiome in Obesity and Diabetes Mellitus
Barlow, G. M., Yu, A., & Mathur, R. (2015) · Nutrition in Clinical Practice · doi:10.1177/0884533615609896 · Cited by 262
Urate‐induced immune programming: Consequences for gouty arthritis and hyperuricemia
Cabău, G., Crișan, T. O., Klück, V., Popp, R. A., & Joosten, L. A. B. (2020) · Immunological Reviews · doi:10.1111/imr.12833 · Cited by 261
The Protective Role of Butyrate against Obesity and Obesity-Related Diseases
Coppola, S., Avagliano, C., Calignano, A., & Berni Canani, R. (2021) · Molecules · doi:10.3390/molecules26030682 · Cited by 261
Modulation of gut microbiota dysbioses in type 2 diabetic patients by macrobiotic Ma-Pi 2 diet
Candela, M., Biagi, E., Soverini, M., Consolandi, C., Quercia, S., Severgnini, M., Peano, C., Turroni, S., Rampelli, S., Pozzilli, P., et al. (2016) · British Journal Of Nutrition · doi:10.1017/s0007114516001045 · Cited by 260
Carciofi, M., Blennow, A., Jensen, S. L., Shaik, S. S., Henriksen, A., Buléon, A., Holm, P. B., & Hebelstrup, K. H. (2012) · BMC Plant Biology · doi:10.1186/1471-2229-12-223 · Cited by 258
Recharla, N., Geesala, R., & Shi, X.-Z. (2023) · Nutrients · doi:10.3390/nu15102275 · Cited by 256
Chung, Y.-L., Lee, M.-Y., Wang, A.-J., & Yao, L.-F. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00235-1 · Cited by 253
Resistant Starch: Physiological Roles and Food Applications
Sharma, A., Yadav, B. S., & Ritika (2008) · Food Reviews International · doi:10.1080/87559120801926237 · Cited by 242
Microbiome disturbances and autism spectrum disorders
Rosenfeld, C. S. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.063826 · Cited by 229
Masui, R., Sasaki, M., Funaki, Y., Ogasawara, N., Mizuno, M., Iida, A., Izawa, S., Kondo, Y., Ito, Y., Tamura, Y., et al. (2013) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000435444.14860.ea · Cited by 217
Benus, R. F. J., van der Werf, T. S., Welling, G. W., Judd, P. A., Taylor, M. A., Harmsen, H. J. M., & Whelan, K. (2010) · British Journal Of Nutrition · doi:10.1017/s0007114510001030 · Cited by 210
Bjørkhaug, S. T., Aanes, H., Neupane, S. P., Bramness, J. G., Malvik, S., Henriksen, C., Skar, V., Medhus, A. W., & Valeur, J. (2019) · Gut Microbes · doi:10.1080/19490976.2019.1580097 · Cited by 205
Russo, E., Giudici, F., Fiorindi, C., Ficari, F., Scaringi, S., & Amedei, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02754 · Cited by 204
The role of the gut microbiota in multiple sclerosis
Correale, J., Hohlfeld, R., & Baranzini, S. E. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00697-8 · Cited by 207
Halili, M. A., Andrews, M. R., Labzin, L. I., Schroder, K., Matthias, G., Cao, C., Lovelace, E., Reid, R. C., Le, G. T., Hume, D. A., et al. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0509363 · Cited by 186
Constante, M., Fragoso, G., Calvé, A., Samba-Mondonga, M., & Santos, M. M. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01809 · Cited by 161
Gut microbiota trajectory in pediatric patients undergoing hematopoietic SCT
Biagi, E., Zama, D., Nastasi, C., Consolandi, C., Fiori, J., Rampelli, S., Turroni, S., Centanni, M., Severgnini, M., Peano, C., et al. (2015) · Bone Marrow Transplantation · doi:10.1038/bmt.2015.16 · Cited by 158
Paineau, D., Payen, F., Panserieu, S., Coulombier, G., Sobaszek, A., Lartigau, I., Brabet, M., Galmiche, J.-P., Tripodi, D., Sacher-Huvelin, S., et al. (2008) · British Journal of Nutrition · doi:10.1017/s000711450779894x · Cited by 142
Self-citationCleophas, M. C. P., Crişan, T. O., Lemmers, H., Toenhake-Dijkstra, H., Fossati, G., Jansen, T. L., Dinarello, C. A., Netea, M. G., & Joosten, L. A. B. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206258 · Cited by 139
Cavaleri, F., & Bashar, E. (2018) · Journal of Nutrition and Metabolism · doi:10.1155/2018/7195760 · Cited by 126
Ouyang, J., Lin, J., Isnard, S., Fombuena, B., Peng, X., Marette, A., Routy, B., Messaoudene, M., Chen, Y., & Routy, J.-P. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00645 · Cited by 124
The human gut microbiota in people with amyotrophic lateral sclerosis
Nicholson, K., Bjornevik, K., Abu-Ali, G., Chan, J., Cortese, M., Dedi, B., Jeon, M., Xavier, R., Huttenhower, C., Ascherio, A., et al. (2021) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2020.1828475 · Cited by 123
Nutritional Risk Factors, Microbiota and Parkinson’s Disease: What Is the Current Evidence?
Boulos, C., Yaghi, N., El Hayeck, R., Heraoui, G. N., & Fakhoury-Sayegh, N. (2019) · Nutrients · doi:10.3390/nu11081896 · Cited by 109
Kim, S. W., Hooker, J. M., Otto, N., Win, K., Muench, L., Shea, C., Carter, P., King, P., Reid, A. E., Volkow, N. D., et al. (2013) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2013.06.007 · Cited by 104
Whole food-based approaches to modulating gut microbiota and associated diseases
Han, Y., & Xiao, H. (2020) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-111519-014337 · Cited by 101
Liu, J., Chang, G., Huang, J., Wang, Y., Ma, N., Roy, A.-C., & Shen, X. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b06359 · Cited by 100
Monk, J. M., Lepp, D., Wu, W., Pauls, K. P., Robinson, L. E., & Power, K. A. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.08.002 · Cited by 85
An investigation into physical frailty as a link between the gut microbiome and cognitive health
Verdi, S., Jackson, M. A., Beaumont, M., Bowyer, R. C. E., Bell, J. T., Spector, T. D., & Steves, C. J. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00398 · Cited by 82
Zhang, Y., Shen, Y., Liufu, N., Liu, L., Li, W., Shi, Z., Zheng, H., Mei, X., Chen, C.-Y., Jiang, Z., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02216-7 · Cited by 83
Roelofsen, H., Priebe, M., & Vonk, R. (2010) · Beneficial Microbes · doi:10.3920/bm2010.0028 · Cited by 80
Brotherton, C. S., Taylor, A. G., Bourguignon, C., & Anderson, J. G. (2014) · Gastroenterology Nursing · doi:10.1097/sga.0000000000000047 · Cited by 78
Benard, C., Cultrone, A., Michel, C., Rosales, C., Segain, J.-P., Lahaye, M., Galmiche, J.-P., Cherbut, C., & Blottière, H. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008666 · Cited by 76
Self-citationGut-microbiota derived bioactive metabolites and their functions in host physiology
Debnath, N., Kumar, R., Kumar, A., Mehta, P. K., & Yadav, A. K. (2021) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.2021.1989847 · Cited by 77
Butyrate modulates gene and protein expression in human intestinal endothelial cells
Ogawa, H., Rafiee, P., Fisher, P. J., Johnson, N. A., Otterson, M. F., & Binion, D. G. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.08.026 · Cited by 70
McGing, J. J., Radford, S. J., Francis, S. T., Serres, S., Greenhaff, P. L., & Moran, G. W. (2021) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16465 · Cited by 60
Seth, R. K., Kimono, D., Alhasson, F., Sarkar, S., Albadrani, M., Lasley, S. K., Horner, R., Janulewicz, P., Nagarkatti, M., Nagarkatti, P., et al. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.05.006 · Cited by 55
Zeissig, S., Fromm, A., Mankertz, J., Weiske, J., Zeitz, M., Fromm, M., & Schulzke, J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.10.033 · Cited by 48
Alam, M., Alam, Q., Kamal, M., Abuzenadah, A., & Haque, A. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113126660151 · Cited by 47
Chattopadhyay, S., Arnold, J. D., Malayil, L., Hittle, L., Mongodin, E. F., Marathe, K. S., Gomez-Lobo, V., & Sapkota, A. R. (2021) · PLOS ONE · doi:10.1371/journal.pone.0245243 · Cited by 45
The Role of Fatty Acid Metabolites in Vaginal Health and Disease: Application to Candidiasis
Baldewijns, S., Sillen, M., Palmans, I., Vandecruys, P., Van Dijck, P., & Demuyser, L. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.705779 · Cited by 44
Fecal microbiome and bile acid metabolome in adult short bowel syndrome
Boutte, H. J., Chen, J., Wylie, T. N., Wylie, K. M., Xie, Y., Geisman, M., Prabu, A., Gazit, V., Tarr, P. I., Levin, M. S., et al. (2022) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00091.2021 · Cited by 33
Narrative review on potential role of gut microbiota in certain substance addiction
Qin, C., Hu, J., Wan, Y., Cai, M., Wang, Z., Peng, Z., Liao, Y., Li, D., Yao, P., Liu, L., et al. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110093 · Cited by 32
Gut microbiome response to short‐term dietary interventions in reactive hypoglycemia subjects
Quercia, S., Turroni, S., Fiori, J., Soverini, M., Rampelli, S., Biagi, E., Castagnetti, A., Consolandi, C., Severgnini, M., Pianesi, M., et al. (2017) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2927 · Cited by 27
Dionizio, A., Uyghurturk, D. A., Melo, C. G. S., Sabino-Arias, I. T., Araujo, T. T., Ventura, T. M. S., Perles, J. V. C. M., Zanoni, J. N., Den Besten, P., & Buzalaf, M. A. R. (2021) · Chemosphere · doi:10.1016/j.chemosphere.2021.129607 · Cited by 21
Metadata
- Authors
- Segain, J.-P., de la Blétière, D. R., Bourreille, A., Leray, V, Gervois, N., Rosales, C., Ferrier, L., Bonnet, C., Blottière, H. M., & Galmiche, J.-P.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2000-09-01
- Volume
- 47
- Issue
- 3
- Pages
- 397-403
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2133547370
- Cited by
- 1,321
- References
- 40
- FWCI
- 8.53
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.